Search Count: 30
![]() |
An Integrated In Silico-In Vitro Workflow For Discovering High-Affinity, Selective Antibodies To The Kras(G12D)-Mhc I Complex
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:4.54 Å Release Date: 2026-06-24 Classification: IMMUNE SYSTEM |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2026-06-24
![]() |
Structure Of Sars-Cov-2 Nsp14 Bound To N-((4-Vinylthiazol-2-Yl)Methyl)-1H-Pyrazole-3-Carboxamide
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2025-12-03 Classification: VIRAL PROTEIN Ligands: ZN, PO4, A1BX0 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-12-03
Ligands: ZN, PO4, A1BX0
![]() |
Structure Of Sars-Cov-2 Nsp14 Bound To N-((4-Cyclopropylthiazol-2-Yl)Methyl)-1H-Pyrazole-3-Carboxamide
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2025-12-03 Classification: VIRAL PROTEIN Ligands: ZN, PO4, A1BXZ |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-12-03
Ligands: ZN, PO4, A1BXZ
![]() |
Structure Of Sars-Cov-2 Nsp14 Bound To N-((4-Isopropylthiazol-2-Yl)Methyl)-1H-Pyrazole-3-Carboxamide
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2025-12-03 Classification: VIRAL PROTEIN Ligands: ZN, PO4, A1BX5 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-12-03
Ligands: ZN, PO4, A1BX5
![]() |
Structure Of Sars-Cov-2 Nsp14 Bound To 5-(((Cyclopropylmethyl)Amino)Methyl)-N-((4-Cyclopropylthiazol-2-Yl)Methyl)-1H-Pyrazole-3-Carboxamide
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2025-12-03 Classification: VIRAL PROTEIN Ligands: ZN, PO4, A1BYF |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-12-03
Ligands: ZN, PO4, A1BYF
![]() |
Sars-Cov-2 Nsp14 Bound To N-((2-Ethynylthiazol-4-Yl)Methyl)-1H-Pyrazole-3-Carboxamide
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2025-12-03 Classification: VIRAL PROTEIN Ligands: ZN, PO4, A1BYG |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-12-03
Ligands: ZN, PO4, A1BYG
![]() |
Structure Of Sars-Cov-2 Nsp14 Bound To N-((4-Cyclopropylthiazol-2-Yl)Methyl)-1H-Pyrazolo[3,4-B]Pyridine-3-Carboxamide
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2025-12-03 Classification: VIRAL PROTEIN Ligands: ZN, PO4, A1BYT |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-12-03
Ligands: ZN, PO4, A1BYT
![]() |
Cryo-Em Structure Of Cxcl1-Kshv Orf74-Gi-Scfv16 Complex
Organism: Homo sapiens, Human gammaherpesvirus 8, Mus musculus
Method: ELECTRON MICROSCOPY Resolution:2.98 Å Release Date: 2025-09-03 Classification: VIRAL PROTEIN/SIGNALING PROTEIN |
Organism: Homo sapiens, Human gammaherpesvirus 8, Mus musculus
Method: ELECTRON MICROSCOPY
Release Date: 2025-09-03
![]() |
Cryo-Em Structure Of Kshv Orf74 Apo Dimer At 2.8A
Organism: Human gammaherpesvirus 8
Method: ELECTRON MICROSCOPY Release Date: 2025-08-27 Classification: VIRAL PROTEIN |
Organism: Human gammaherpesvirus 8
Method: ELECTRON MICROSCOPY
Release Date: 2025-08-27
![]() |
Crystal Structure Of Sars-Cov-2 Alpha Rbd In Complex With The D27Ley Neutralizing Antibody Fab Fragment
Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:3.51 Å Release Date: 2023-06-28 Classification: ANTIVIRAL PROTEIN/VIRAL PROTEIN |
Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-06-28
![]() |
Sars-Cov-2 3Clpro In Complex With 2-(Benzotriazol-1-Yl)-N-[4-(1H-Pyrazol-4-Yl)Phenyl]-N-(3-Thienylmethyl)Acetamide
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.96 Å Release Date: 2021-08-11 Classification: VIRAL PROTEIN, hydrolase/Inhibitor Ligands: Y6A |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2021-08-11
Ligands: Y6A
![]() |
Sars-Cov-2 3Clpro In Complex With N-[4-[[2-(Benzotriazol-1-Yl)Acetyl]-(3-Thienylmethyl)Amino]Phenyl]Cyclopropanecarboxamide
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2021-08-11 Classification: VIRAL PROTEIN, Hydrolase/Inhibitor Ligands: Y6J |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2021-08-11
Ligands: Y6J
![]() |
Sars-Cov-2 3Clpro In Complex With 2-(Benzotriazol-1-Yl)-N-[4-(1H-Imidazol-4-Yl)Phenyl]-N-(3-Thienylmethyl)Acetamide
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2021-08-11 Classification: VIRAL PROTEIN, Hydrolase/Inhibitor Ligands: Y6G |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2021-08-11
Ligands: Y6G
![]() |
Sars-Cov-1 3Clpro In Complex With N-(4-(1H-Imidazol-4-Yl)Phenyl)-2-(1H-Benzo[D][1,2,3]Triazol-1-Yl)-N-(Thiophen-3-Ylmethyl)Acetamide
Organism: Severe acute respiratory syndrome coronavirus
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-08-11 Classification: VIRAL PROTEIN, Hydrolase/Inhibitor Ligands: GOL, Y6G, PEG |
Organism: Severe acute respiratory syndrome coronavirus
Method: X-RAY DIFFRACTION
Release Date: 2021-08-11
Ligands: GOL, Y6G, PEG
![]() |
Sars-Cov-1 3Clpro In Complex With 2-(1H-Benzo[D][1,2,3]Triazol-1-Yl)-N-(4-(Pyridin-3-Yl)Phenyl)-N-(Thiophen-3-Ylmethyl)Acetamide
Organism: Severe acute respiratory syndrome coronavirus
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2021-08-11 Classification: VIRAL PROTEIN, Hydrolase/Inhibitor Ligands: Y6D, GOL |
Organism: Severe acute respiratory syndrome coronavirus
Method: X-RAY DIFFRACTION
Release Date: 2021-08-11
Ligands: Y6D, GOL
![]() |
Sars-Cov-1 3Clpro In Complex With N-(4-(1H-Pyrazol-4-Yl)Phenyl)-2-(1H-Benzo[D][1,2,3]Triazol-1-Yl)-N-(Thiophen-3-Ylmethyl)Acetamide
Organism: Severe acute respiratory syndrome coronavirus
Method: X-RAY DIFFRACTION Resolution:1.71 Å Release Date: 2021-08-11 Classification: VIRAL PROTEIN, Hydrolase/Inhibitor Ligands: GOL, Y6A |
Organism: Severe acute respiratory syndrome coronavirus
Method: X-RAY DIFFRACTION
Release Date: 2021-08-11
Ligands: GOL, Y6A
![]() |
Sars-Cov-1 3Clpro In Complex With 2-(1H-Benzo[D][1,2,3]Triazol-1-Yl)-N-(3-Chlorobenzyl)-N-(4-(2-Oxo-1,2-Dihydropyridin-3-Yl)Phenyl)Acetamide
Organism: Severe acute respiratory syndrome coronavirus
Method: X-RAY DIFFRACTION Resolution:1.69 Å Release Date: 2021-08-11 Classification: VIRAL PROTEIN, Hydrolase/Inhibitor Ligands: PEG, GOL, Y67 |
Organism: Severe acute respiratory syndrome coronavirus
Method: X-RAY DIFFRACTION
Release Date: 2021-08-11
Ligands: PEG, GOL, Y67
![]() |
Sftsv L Endonuclease Domain
Organism: Severe fever with thrombocytopenia virus
Method: X-RAY DIFFRACTION Resolution:2.40 Å Release Date: 2020-01-08 Classification: TRANSCRIPTION |
Organism: Severe fever with thrombocytopenia virus
Method: X-RAY DIFFRACTION
Release Date: 2020-01-08
![]() |
Structure Of Dotl(656-783)-Icms-Icmw Derived From Legionella Pneumophila
Organism: Legionella pneumophila subsp. pneumophila (strain philadelphia 1 / atcc 33152 / dsm 7513)
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2017-06-14 Classification: PROTEIN TRANSPORT |
![]() |
Structure Of Legionella Pneumophila Dotn
Organism: Legionella pneumophila subsp. pneumophila (strain philadelphia 1 / atcc 33152 / dsm 7513)
Method: X-RAY DIFFRACTION Resolution:3.01 Å Release Date: 2017-06-14 Classification: PROTEIN TRANSPORT Ligands: ZN |
Organism: Legionella pneumophila subsp. pneumophila (strain philadelphia 1 / atcc 33152 / dsm 7513)
Method: X-RAY DIFFRACTION
Release Date: 2017-06-14
Ligands: ZN
